One Versus Two Unit Transfusions in Oncology Patients - The OTTOP Trial: A Randomized Open-label Pragmatic Controlled Trial
NCT04544540 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450
Last updated 2020-09-10
Summary
The aim of this trial is to determine if the transfusion of one unit of red blood cells to anemic oncology patients results in comparable numbers of transfusion episodes when compared to transfusion of two units of red blood cells.
Conditions
Interventions
- OTHER
-
Units of transfusion
Participants will either receive 1-unit or 2-unit red blood cell outpatient transfusions
Sponsors & Collaborators
-
Ottawa Hospital Research Institute
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-01
- Primary Completion
- 2023-11-01
- Completion
- 2024-12-01
More Related Trials
-
Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia
NCT03520049 ·Status: UNKNOWN ·Phase: PHASE3
-
Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia
NCT03195010 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia
NCT04896528 ·Status: UNKNOWN ·Phase: PHASE2
-
TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia
NCT03136445 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of MegaLT Injection for Treating Refractory Thrombocytopenia Following Radiotherapy, Chemotherapy, or Transplantation.
NCT06534255 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma
NCT00151866 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy
NCT01319669 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
rhTPO in Critical Patients With Thrombocytopenia
NCT02094248 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Randomized, Multi-center, Open-label, Paired Controlled, Crossover In Vivo Study
NCT02653443 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)
NCT06352281 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia
NCT02718716 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)
NCT06094881 ·Status: RECRUITING ·Phase: PHASE2
-
An Investigation of rhTPO With Different Frequencies in the Management of ITP
NCT02139501 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT
NCT01286675 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Optimal Platelet Dose Strategy for Management of Thrombocytopenia
NCT00128713 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia
NCT05995054 ·Status: RECRUITING ·Phase: PHASE2
-
Cold Versus Room Temperature Storage of Platelets for Bleeding in Hematologic Malignancy - a Pilot Trial
NCT05820126 ·Status: RECRUITING ·Phase: PHASE2
-
Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)
NCT04448184 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device
NCT01210716 ·Status: COMPLETED ·Phase: PHASE3
-
Bleeding In Thrombocytopenia Explained
NCT03505086 ·Status: RECRUITING
-
A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia
NCT04278924 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study of Herombopag in Tumors-associated Thrombocytopenia
NCT05350956 ·Status: UNKNOWN ·Phase: PHASE2
-
Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients
NCT00926354 ·Status: TERMINATED ·Phase: PHASE2
-
Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia
NCT02244658 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Study of Combined Platelet Transfusion
NCT06613425 ·Status: RECRUITING ·Phase: PHASE4